{"data":[{"accessionNo":"0001897612-26-000635","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC","ticker":"BCAX","cusip":"055477103","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":2804772,"percentOfClass":4.2,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001274173-26-000198","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC.","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":3171015,"percentOfClass":4.8,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0002012383-26-002268","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":3536271,"percentOfClass":5.4,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0000902664-26-002552","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0002023658","issuerName":"Bicara Therapeutics Inc.","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":5425000,"percentOfClass":8.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0000902664-26-002552","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0002023658","issuerName":"Bicara Therapeutics Inc.","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":5425000,"percentOfClass":8.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001172661-26-002025","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"Bicara Therapeutics Inc.","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":4062500,"percentOfClass":6.21,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001172661-26-002025","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"Bicara Therapeutics Inc.","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":4062500,"percentOfClass":6.21,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001172661-26-002025","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"Bicara Therapeutics Inc.","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":4062500,"percentOfClass":6.21,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001274173-26-000128","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC.","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":3339218,"percentOfClass":5.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001995961-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC.","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Heath Lukatch","reportingCik":null,"personType":"IN","sharesOwned":3170509,"percentOfClass":4.8,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001995961-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC.","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Red Tree Venture Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3170509,"percentOfClass":4.8,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001995961-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC.","ticker":"BCAX","cusip":"055477103","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Red Tree GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":3170509,"percentOfClass":4.8,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0000315066-26-001100","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC","ticker":"BCAX","cusip":"055477103","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":2100929,"percentOfClass":3.2,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0000315066-26-001100","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC","ticker":"BCAX","cusip":"055477103","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":2100929,"percentOfClass":3.2,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001897612-26-000342","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC","ticker":"BCAX","cusip":"055477103","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":6605780,"percentOfClass":10.1,"filedAt":"2026-04-08","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001346824-26-000066","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC.","ticker":"BCAX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-26","reportingPerson":"RA Capital Management, L.P.","reportingCik":"0001346824","personType":"IA,PN","sharesOwned":7279739,"percentOfClass":11.5,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001346824-26-000066","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC.","ticker":"BCAX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-26","reportingPerson":"Peter Kolchinsky","reportingCik":"0001384859","personType":"HC,IN","sharesOwned":7279739,"percentOfClass":11.5,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001346824-26-000066","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC.","ticker":"BCAX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-26","reportingPerson":"Rajeev Shah","reportingCik":"0001619841","personType":"HC,IN","sharesOwned":7279739,"percentOfClass":11.5,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001346824-26-000066","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC.","ticker":"BCAX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-26","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":"0001315082","personType":"PN","sharesOwned":4603418,"percentOfClass":7.3,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0000902664-26-001089","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0002023658","issuerName":"Bicara Therapeutics Inc.","ticker":"BCAX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3575000,"percentOfClass":6.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0000902664-26-001089","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0002023658","issuerName":"Bicara Therapeutics Inc.","ticker":"BCAX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":3575000,"percentOfClass":6.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001897612-26-000288","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC","ticker":"BCAX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":3236595,"percentOfClass":5.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001172661-26-000689","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002023658","issuerName":"Bicara Therapeutics Inc.","ticker":"BCAX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-05","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":2750000,"percentOfClass":5.02,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001172661-26-000689","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002023658","issuerName":"Bicara Therapeutics Inc.","ticker":"BCAX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-05","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":2750000,"percentOfClass":5.02,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0001172661-26-000689","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002023658","issuerName":"Bicara Therapeutics Inc.","ticker":"BCAX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-02-05","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":2750000,"percentOfClass":5.02,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0000315066-26-000365","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC","ticker":"BCAX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":3347223,"percentOfClass":6.1,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"},{"accessionNo":"0000315066-26-000365","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002023658","issuerName":"BICARA THERAPEUTICS INC","ticker":"BCAX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":3347223,"percentOfClass":6.1,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/bcax"}],"updatedAt":"2026-11-04T07:02:28.888Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/bcax","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}